Viewing Study NCT00515892


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-03 @ 12:38 AM
Study NCT ID: NCT00515892
Status: UNKNOWN
Last Update Posted: 2007-08-14
First Post: 2007-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
Sponsor: Cambridge Antibody Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Non-Hodgkin's Lymphoma View
None NHL View
Keywords: